Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Chula Vista › NPI 1366053167
Clinic

Centro De Salud De LA Comunidad De San Ysidro, INC

Centro De Salud De LA Comunidad De San Ysidro, INC was paid $13.00M by Medicaid between Jan 2021 and Dec 2024, across 52 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 98% of everything it billed.

33Billing provider infoCENTRO DE SALUD DE LA COMUNIDAD DE SAN YSIDRO, INC
CHULA VISTA, CA 91910
33aNPI1366053167assigned 08/14/2020
28Total paid$13.00M
24GClaims221,891
24DCodes billed52
24AFirst – last monthJan 2021 – Dec 2024
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in California

Rank by total paid#252 of 826
Median peer was paid$4.05M
This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202124,830$501K
202249,652$2.65M
202393,222$5.07M
2024incomplete54,187$4.79M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 98% 57,486 56,852 $12.73M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity <1% 25,677 24,070 $90K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity <1% 13,143 12,302 $62K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity <1% 2,619 2,270 $49K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 2,708 2,549 $14K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 5,112 4,833 $12K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,808 2,642 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 6,389 6,005 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,789 2,639 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,642 4,386 $3K
G0467 Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit <1% 93 80 $3K
93000 <1% 1,034 972 $2K
40 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,040 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 123 $2K
99000 <1% 5,511 $1K
81025 <1% 2,736 $892.46
99204 Doctor's office visit, new patient (more involved) <1% 57 $891.33
81002 <1% 6,270 $785.70
80048 Basic metabolic panel (calcium, ionized) <1% 799 $323.80
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,435 $302.48
80047 <1% 468 $285.39
85007 <1% 1,238 $232.61
89240 <1% 793 $133.67
87420 <1% 190 $96.44
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 68 $38.70
36415 Collection of venous blood by venipuncture <1% 2,199 $28.20
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 9,659 $6.33
82962 <1% 13 $2.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 66 $0.14
1159F <1% 8,017 $0.02
3079F 0% 3,771 $0.00
3351F 0% 144 $0.00
3074F 0% 9,769 $0.00
3008F 0% 5,013 $0.00
3075F 0% 1,144 $0.00
1125F 0% 5,449 $0.00
2010F 0% 12,493 $0.00
1126F 0% 1,426 $0.00
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 0% 654 $0.00
3080F 0% 752 $0.00
3120F 0% 84 $0.00
4010F 0% 27 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 47 $0.00
84512 0% 14 $0.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 0% 12 $0.00
87807 0% 17 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 13 $0.00
3077F 0% 1,863 $0.00
3078F 0% 8,364 $0.00
3028F 0% 4,589 $0.00
G9920 Screening performed and negative 0% 26 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 38 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWALLACE, WILLIAM (VP/CFO)
Same official

Other billing entities under WALLACE, WILLIAM

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.